Cell-Specific Aptamer-Functionalized RNAi: A New Prospect for Targeted siRNA Delivery - Nanotechnology for the Delivery of Therapeutic Nucleic Acids - page 122

22. Zhou, J, and Rossi, JJ (2009). The therapeutic potential of cell-
internalizing aptamers. . pp. 1144-1157.

23. Zhou, J, and Rossi, JJ (2011). Cell-specific aptamer-mediated targeted
drug delivery.

Curr Top Med Chem , 9

. pp. 1-10.
24. Ellington, AD, and Szostak, JW (1990).

Oligonucleotides , 21

In vitro selection of RNA

. pp. 818-822.
25. Tuerk, C, and Gold, L (1990). Systematic evolution of ligands by
exponential enrichment: RNA ligands to bacteriophage T4 DNA
polymerase.

molecules that bind specific ligands. Nature , 346

. pp. 505-510.
26. Robertson, DL, and Joyce, GF (1990). Selection

Science , 249

in vitro of an RNA

enzyme that specifically cleaves single-stranded DNA. Nature , 344 .

pp. 467-468.
27. Lupold, SE, Hicke, BJ, Lin, Y, and Coffey, DS (2002). Identification
and characterization of nuclease-stabilized RNA molecules that bind
human prostate cancer cells via the prostate-specific membrane
antigen. . pp. 4029-4033.

28. Kraus, E, James, W, and Barclay, AN (1998). Cutting edge: novel RNA
ligands able to bind CD4 antigen and inhibit CD4+ T lymphocyte
function.

Cancer Res , 62

. pp. 5209-5212.
29. Mori, T, Oguro, A, Ohtsu, T, and Nakamura, Y (2004). RNA aptamers
selected against the receptor activator of NF-kappaB acquire general
affinity to proteins of the tumor necrosis factor receptor family.

J Immunol , 160

Nucleic

. pp. 6120-6128.
30. Somasunderam, A,

Acids Res , 32

. (2010). Combinatorial selection of DNA
thioaptamers targeted to the HA binding domain of human CD44.
Biochemistry

et al

, 49 . pp. 9106-9112.

31. Zhou, J, . (2009). Selection, characterization and application of

new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate
siRNAs into HIV infected cells.

et al

. pp. 3094-3109
32. Dey, AK, Khati, M, Tang, M, Wyatt, R, Lea, SM, and James, W (2005). An
aptamer that neutralizes R5 strains of human immunodeficiency virus
type 1 blocks gp120-CCR5 interaction.

Nucleic Acids Res , 37

J Virol , 79 . pp. 13806-13810.

33. Hicke, BJ, et al . (2006). Tumor targeting by an aptamer. J Nucl Med , 47 .

pp. 668-678.
34. Li, N, Larson, T, Nguyen, HH, Sokolov, KV, and Ellington, AD (2010).
Directed evolution of gold nanoparticle delivery to cells.

Chem Commun

. pp. 392-394.
35. Shangguan, D,

( Camb ), 46

. (2006). Aptamers evolved from live cells as
effective molecular probes for cancer study.

et al

Proc Natl Acad Sci USA ,

103 . pp. 11838-11843.